Cancer medicines
Dasatinib
Dasatinib
A targeted therapy for Philadelphia chromosome-positive leukemias.
Sources checked · Introductory guide
On this page
How it works
It inhibits growth signaling through tyrosine kinases including BCR-ABL.[3]
Where it is used
Used in selected Ph-positive CML or ALL according to disease status and prior treatment.[1]
Key safety points
Report new breathlessness, chest pain, swelling or bleeding immediately. Review all medicines, including acid suppressants and antacids.[2]
Questions for your care team
- How are molecular response, lung or heart symptoms and gastric-medicine interactions monitored?
Sources and scope
Source documents are in English.
Entries summarize and translate linked official public sources. The source-check date records when those sources were checked; it does not indicate a clinician’s review.
- NCI · Dasatinib (opens in a new tab)
- MedlinePlus · Dasatinib (opens in a new tab)
- NCI Drug Dictionary · Dasatinib (opens in a new tab)
General information based on official public sources. This is not a complete list of uses or side effects. Individual treatment decisions require your care team and current source documents. US-source uses do not establish local approval or reimbursement.